Stefan Agewall
English version of this page
Brukernavn
Besøksadresse
Kirkeveien 166
Bygning 3
0450 Oslo
Postadresse
Postboks 4956 Nydalen
OUS HF Ullevål sykehus
0424 Oslo
Publikasjoner
-
Xiong, Wei; Agewall, Stefan & Yamashita, Yugo (2024). Anticoagulation in cancer-associated thrombosis: how long should the therapy be? European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 10(1), s. 3–4. doi: 10.1093/ehjcvp/pvad075.
-
Tjessem, Lars Holm & Agewall, Stefan (2023). EVALUATION OF A STRUCTURALIZED SICK-LEAVE PROGRAMME COMPARED WITH USUAL CARE SICK-LEAVE MANAGEMENT FOR PATIENTS AFTER AN ACUTE MYOCARDIAL INFARCTION. Journal of Rehabilitation Medicine. ISSN 1650-1977. 55. doi: 10.2340/jrm.v55.4569. Fulltekst i vitenarkiv
-
Seekircher, Lisa; Tschiderer, Lena; Lind, Lars; Safarova, Maya S; Kavousi, Maryam & Ikram, M. Arfan [Vis alle 39 forfattere av denne artikkelen] (2023). Intima-media thickness at the near or far wall of the common carotid artery in cardiovascular risk assessment. European Heart Journal Open (EHJ Open). 3(5). doi: 10.1093/ehjopen/oead089. Fulltekst i vitenarkiv
-
Berg, Emma; Agewall, Stefan; Brolin, Elin B.; Caidahl, Kenneth; Cederlund, Kerstin & Collste, Olov [Vis alle 16 forfattere av denne artikkelen] (2023). Health-related quality-of-life up to one year after myocardial infarction with non-obstructive coronary arteries. European Heart Journal - Quality of Care and Clinical Outcomes. ISSN 2058-5225. 9(6), s. 639–644. doi: 10.1093/ehjqcco/qcac072. Fulltekst i vitenarkiv
-
Wärme, Jonatan; Sundqvist, Martin O.; Hjort, Marcus; Agewall, Stefan; Collste, Olov & Ekenbäck, Christina [Vis alle 16 forfattere av denne artikkelen] (2023). Helicobacter pylori and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease. International Journal of Molecular Sciences. ISSN 1661-6596. 24(18). doi: 10.3390/ijms241814143. Fulltekst i vitenarkiv
-
Drexel, Heinz; Tamargo, Juan; Kaski, Juan Carlos; Lewis, Basil S.; Saely, Christoph H. & Fraunberger, Peter [Vis alle 11 forfattere av denne artikkelen] (2023). Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease? European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(6), s. 570–582. doi: 10.1093/ehjcvp/pvad044.
-
Fröhlich, Hanna; Bossmeyer, Anna; Kazmi, Syed; Goode, Kevin M.; Agewall, Stefan & Atar, Dan [Vis alle 12 forfattere av denne artikkelen] (2023). Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus. Clinical Research in Cardiology. ISSN 1861-0684. doi: 10.1007/s00392-023-02268-3. Fulltekst i vitenarkiv Vis sammendrag
-
Tschiderer, Lena; Seekircher, Lisa; Izzo, Raffaele; Mancusi, Costantino; Manzi, Maria V. & Baldassarre, Damiano [Vis alle 63 forfattere av denne artikkelen] (2023). Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies. Journal of the American Heart Association (JAHA). ISSN 2047-9980. 12(12). doi: 10.1161/JAHA.122.027657. Fulltekst i vitenarkiv
-
Tamargo, Juan; Agewall, Stefan; Borghi, Claudio; Ceconi, Claudio; Cerbai, Elisabetta & Dan, Gheorghe A. [Vis alle 15 forfattere av denne artikkelen] (2023). New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(4), s. 353–370. doi: 10.1093/ehjcvp/pvad034.
-
Drexel, Heinz; Saely, Christoph H. & Agewall, Stefan (2023). Fibrates: one more lost paradise in lipid treatment. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(2). doi: 10.1093/ehjcvp/pvac072.
-
Martínez-Montesinos, Lorena; Rivera-Caravaca, José Miguel; Agewall, Stefan; Soler, Eva; Lip, Gregory Y.H. & Marín, Francisco [Vis alle 7 forfattere av denne artikkelen] (2023). Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity? Biomedicine & Pharmacotherapy. ISSN 0753-3322. 158. doi: 10.1016/j.biopha.2022.114064. Fulltekst i vitenarkiv
-
Nguyen, Thao; Fagerland, Morten; Hollan, Ivana; Whist, Jon Elling; Feinberg, Mark W. & Agewall, Stefan (2023). High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis. PLOS ONE. ISSN 1932-6203. 18:e0281155.(2), s. 1–10. doi: 10.1371/journal.pone.0281155. Fulltekst i vitenarkiv Vis sammendrag
-
Komiyama, Maki; Agewall, Stefan & Hasegawa, Koji (2022). Future of antithrombotic therapy for heart failure with coronary artery disease. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. doi: 10.1093/ehjcvp/pvac030.
-
Hokstad, Ingrid; Greco, Daniela; Deyab, Gia; Fagerland, Morten; Agewall, Stefan & Hjeltnes, Gunnbjørg [Vis alle 10 forfattere av denne artikkelen] (2022). Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies. Journal of Clinical Medicine. ISSN 2077-0383. 11(24). doi: 10.3390/jcm11247330. Fulltekst i vitenarkiv Vis sammendrag
-
Tamargo, Juan; Kaski, Juan Carlos; Kimura, Takeshi; Barton, Jack Charles; Yamamoto, Ko & Komiyama, Maki [Vis alle 10 forfattere av denne artikkelen] (2022). Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(7), s. 738–751. doi: 10.1093/ehjcvp/pvac040.
-
Drexel, Heinz; Pocock, Stuart J; Lewis, Basil S; Saely, Christoph H; Kaski, Juan Carlos & Rosano, Giuseppe M. C [Vis alle 19 forfattere av denne artikkelen] (2022). Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(3), s. 302–310. doi: 10.1093/ehjcvp/pvab048. Fulltekst i vitenarkiv
-
Tamargo, Juan; Kjeldsen, Keld Per; Delpon, Eva; Semb, Anne Grete; Cerbai, Elisabetta & Dobrev, Dobromir [Vis alle 19 forfattere av denne artikkelen] (2022). Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(4), s. 406–419. doi: 10.1093/ehjcvp/pvac005.
-
El Hadidi, Seif; Rosano, Giuseppe; Tamargo, Juan; Agewall, Stefan; Drexel, Heinz & Kaski, Juan Carlos [Vis alle 10 forfattere av denne artikkelen] (2022). Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(2), s. 187–210. doi: 10.1093/ehjcvp/pvaa108.
-
Magavern, Emma F.; Kaski, Juan Carlos; Turner, Richard M.; Drexel, Heinz; Janmohamed, Azara & Scourfield, Andrew [Vis alle 21 forfattere av denne artikkelen] (2022). Challenges in cardiovascular pharmacogenomics implementation: A viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(1), s. 100–103. doi: 10.1093/ehjcvp/pvab063.
-
Magavern, Emma Forton; Kaski, Juan Carlos; Turner, Richard M.; Drexel, Heinz; Janmohamed, Azara & Scourfield, Andrew [Vis alle 21 forfattere av denne artikkelen] (2022). The role of pharmacogenomics in contemporary cardiovascular therapy: A position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(1), s. 85–99. doi: 10.1093/ehjcvp/pvab018.
-
Hall, Trygve Sørdahl; Ørn, Stein; Zannad, Faiez; Rossignol, Patrick; Duarte, Kevin & Solomon, Scott D. [Vis alle 10 forfattere av denne artikkelen] (2022). The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction. Journal of Women's Health. ISSN 1540-9996. 31(3), s. 310–320. doi: 10.1089/jwh.2021.0326.
-
Nguyen, Thao; Hokstad, Ingrid; Fagerland, Morten; Mollnes, Tom Eirik; Hollan, Ivana & Feinberg, Mark W. [Vis alle 10 forfattere av denne artikkelen] (2022). Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis. PLOS ONE. ISSN 1932-6203. 17 (2), s. 1–18. doi: 10.1371/journal.pone.0264628. Fulltekst i vitenarkiv Vis sammendrag
-
Sörensson, Peder; Ekenbäck, Christina; Lundin, Magnus; Agewall, Stefan; Bacsovics Brolin, Elin & Caidahl, Kenneth [Vis alle 20 forfattere av denne artikkelen] (2021). Early Comprehensive Cardiovascular Magnetic Resonance Imaging in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries. JACC Cardiovascular Imaging. ISSN 1936-878X. 14(9), s. 1774–1783. doi: 10.1016/j.jcmg.2021.02.021. Fulltekst i vitenarkiv
-
Tamargo, Juan & Agewall, Stefan (2021). Fluoroquinolone use and valvular heart disease: Is the jury still out? European Heart Journal. ISSN 0195-668X. 42(30), s. 2909–2911. doi: 10.1093/eurheartj/ehab426.
-
Drexel, Heinz; Lewis, Basil S.; Rosano, Giuseppe M. C.; Saely, Christoph H.; Tautermann, Gerda & Huber, Kurt [Vis alle 18 forfattere av denne artikkelen] (2021). The age of randomized clinical trials: Three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 7(5), s. 453–459. doi: 10.1093/ehjcvp/pvaa126.
-
Deyab, Gia; Reine, Trine M.; Vuong, Tram Thu; Jenssen, Trond Geir; Hjeltnes, Gunnbjørg & Agewall, Stefan [Vis alle 11 forfattere av denne artikkelen] (2021). Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis. PLOS ONE. ISSN 1932-6203. 16(7). doi: 10.1371/journal.pone.0253247. Fulltekst i vitenarkiv Vis sammendrag
-
Svenungsson, Elisabet; Spaak, Jonas; Strandberg, Karin; Wallén, Håkan N.; Agewall, Stefan & Brolin, Elin B. [Vis alle 17 forfattere av denne artikkelen] (2021). Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries. Journal of Internal Medicine. ISSN 0954-6820. doi: 10.1111/joim.13409. Fulltekst i vitenarkiv
-
Krogager, Maria Lukács; Kragholm, Kristian; Thomassen, Jesper Qvist; Søgaard, Peter; Lewis, Basil S & Wassmann, Sven [Vis alle 19 forfattere av denne artikkelen] (2021). Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: A review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 7(6), s. 557–567. doi: 10.1093/ehjcvp/pvab038.
-
Nguyen, Thao; Fagerland, Morten; Deyab, Gia; Hjeltnes, Gunnbjørg; Hollan, Ivana & Feinberg, Mark W. [Vis alle 9 forfattere av denne artikkelen] (2021). Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis. PLOS ONE. ISSN 1932-6203. 16:e0253793(6), s. 1–17. doi: 10.1371/journal.pone.0253793. Fulltekst i vitenarkiv Vis sammendrag
-
Täger, Tobias; Frankenstein, Lutz; Atar, Dan; Agewall, Stefan; Frey, Norbert & Grundtvig, Morten [Vis alle 9 forfattere av denne artikkelen] (2021). Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis. Clinical Research in Cardiology. ISSN 1861-0684. doi: 10.1007/s00392-021-01913-z. Fulltekst i vitenarkiv Vis sammendrag
-
Y-Hassan, Shams; Sörensson, Peder; Ekenbäck, Christina; Lundin, Magnus; Agewall, Stefan & Brolin, Elin Bacsovics [Vis alle 20 forfattere av denne artikkelen] (2021). Plasma catecholamine levels in the acute and subacute stages of takotsubo syndrome: Results from the Stockholm myocardial infarction with normal coronaries 2 study. Clinical Cardiology. ISSN 0160-9289. doi: 10.1002/clc.23723. Fulltekst i vitenarkiv
-
Tschiderer, Lena; Seekircher, Lisa; Klingenschmid, Gerhard; Izzo, Raffaele; Baldassarre, Damiano & Iglseder, Bernhard [Vis alle 63 forfattere av denne artikkelen] (2020). The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and Rationale. Gerontology. ISSN 0304-324X. 66(5), s. 447–459. doi: 10.1159/000508498.
-
Lewis, Basil S.; Agewall, Stefan & Rosano, Giuseppe (2020). MSc in clinical trials: a new flagship Working Group project. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(5). doi: 10.1093/ehjcvp/pvaa078.
-
Willeit, Peter; Tschiderer, Lena; Allara, Elias; Reuber, Kathrin; Seekircher, Lisa & Gao, Lu [Vis alle 76 forfattere av denne artikkelen] (2020). Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk : Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients. Circulation. ISSN 0009-7322. 142(7), s. 621–642. doi: 10.1161/CIRCULATIONAHA.120.046361. Vis sammendrag
-
Drexel, Heinz; Rosano, Giuseppe; Lewis, Basil S.; Huber, Kurt; Vonbank, Alexander & Dopheide, Jörn F [Vis alle 11 forfattere av denne artikkelen] (2020). The age of randomized clinical trials: Three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(2), s. 97–103. doi: 10.1093/ehjcvp/pvz029. Fulltekst i vitenarkiv
-
Täger, Tobias; Atar, Dan; Agewall, Stefan; Katus, Hugo A.; Grundtvig, Morten & Cleland, John G.F. [Vis alle 9 forfattere av denne artikkelen] (2020). Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials. Heart Failure Reviews. ISSN 1382-4147. s. 1–15. doi: 10.1007/s10741-020-09954-8. Fulltekst i vitenarkiv Vis sammendrag
-
Knuuti, Juhani; Wijns, William; Saraste, Antti; Capodanno, Davide; Barbato, Emanuele & Funck-Brentano, Christian [Vis alle 25 forfattere av denne artikkelen] (2020). 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal. ISSN 0195-668X. 41(3), s. 407–477. doi: 10.1093/eurheartj/ehz425.
-
Savarese, Gianluigi; Reiner, Martin F; Uijl, Alicia; D'Amario, Domenico; Agewall, Stefan & Atar, Dan [Vis alle 23 forfattere av denne artikkelen] (2020). Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(2), s. 86–93. doi: 10.1093/ehjcvp/pvz036. Fulltekst i vitenarkiv
-
Bahls, Martin; Lorenz, Matthias W.; Dörr, Marcus; Gao, Lu; Kitagawa, Kazuo & Tuomainen, Tomi-Pekka [Vis alle 55 forfattere av denne artikkelen] (2020). Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium. European Journal of Preventive Cardiology (EJPC). ISSN 2047-4873. 27(3), s. 234–243. doi: 10.1177/2047487319877078. Fulltekst i vitenarkiv
-
Rosano, Giuseppe M.C.; Spoletini, Ilaria; Vitale, Cristina & Agewall, Stefan (2019). Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction. Cardiac failure review. ISSN 2057-7540. 5(3), s. 130–132. doi: 10.15420/cfr.2019.8.2. Fulltekst i vitenarkiv
-
Hollan, Ivana; Ronda, Nicoletta; Dessein, Patrick; Agewall, Stefan; Karpouzas, George & Tamargo, Juan [Vis alle 12 forfattere av denne artikkelen] (2019). Lipid management in rheumatoid arthritis: a position paper by the Cardiovascular Pharmacotherapy Working Group of European Society of Cardiology. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(2), s. 104–114. doi: 10.1093/ehjcvp/pvz033.
-
von Lueder, Thomas Gero; Atar, Dan; Agewall, Stefan; Jensen, Jesper K; Hopper, Ingrid & Kotecha, Dipak [Vis alle 9 forfattere av denne artikkelen] (2019). All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System . American Journal of Therapeutics. ISSN 1075-2765. 26(6), s. e671–e678. doi: 10.1097/MJT.0000000000000883. Fulltekst i vitenarkiv
-
Hjort, Marcus; Eggers, Kai M.; Lindhagen, Lars; Agewall, Stefan; Brolin, Elin B. & Collste, Olov [Vis alle 17 forfattere av denne artikkelen] (2019). Increased inflammatory activity in patients 3 months after myocardial infarction with nonobstructive coronary arteries. Clinical Chemistry. ISSN 0009-9147. 65(8), s. 1023–1030. doi: 10.1373/clinchem.2018.301085.
-
Hall, Trygve Sørdahl; von Lueder, Thomas Gero; Zannad, Faïez; Rossignol, Patrick; Duarte, Kévin & Chouihed, Tahar [Vis alle 11 forfattere av denne artikkelen] (2019). Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction. American Heart Journal. ISSN 0002-8703. 215, s. 83–90. doi: 10.1016/j.ahj.2019.06.004. Fulltekst i vitenarkiv
-
Hokstad, Ingrid; Deyab, Gia; Fagerland, Morten; Lyberg, Torstein; Hjeltnes, Gunnbjørg & Førre, Øystein Thorleiv [Vis alle 9 forfattere av denne artikkelen] (2019). Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study. PLOS ONE. ISSN 1932-6203. 14(7), s. 1–16. doi: 10.1371/journal.pone.0220079. Fulltekst i vitenarkiv Vis sammendrag
-
Sulzgruber, Patrick; Wassmann, Sven; Semb, Anne Grete; Doehner, Wolfram; Widimský, Petr & Gremmel, Thomas [Vis alle 19 forfattere av denne artikkelen] (2019). Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(3), s. 171–180. doi: 10.1093/ehjcvp/pvz016. Fulltekst i vitenarkiv
-
Rosano, Giuseppe M.C.; Spoletini, Ilaria & Agewall, Stefan (2019). Pharmacology of new treatments for hyperkalaemia: Patiromer and sodium zirconium cyclosilicate. European Heart Journal, Supplement. ISSN 1520-765X. 21, s. A28–A33. doi: 10.1093/eurheartj/suy035. Fulltekst i vitenarkiv
-
Hausvater, Anais; Pasupathy, Sivabaskari; Tornvall, Per; Gandhi, Himali; Tavella, Rosanna & Beltrame, John [Vis alle 12 forfattere av denne artikkelen] (2019). ST-segment elevation and cardiac magnetic resonance imaging findings in myocardial infarction with non-obstructive coronary arteries. International Journal of Cardiology. ISSN 0167-5273. 287, s. 128–131. doi: 10.1016/j.ijcard.2019.04.028.
-
Täger, Tobias; Fröhlich, Hanna; Grundtvig, Morten; Seiz, Mirjam; Schellberg, Dieter & Goode, Kevin [Vis alle 14 forfattere av denne artikkelen] (2019). Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure – A multicenter propensity score matched analysis. International Journal of Cardiology. ISSN 0167-5273. 289, s. 83–90. doi: 10.1016/j.ijcard.2019.01.109. Fulltekst i vitenarkiv Vis sammendrag
-
Navarese, Eliano Pio; Andreotti, Felicita; Raggi, Paolo; Kolodziejczak, Michalina; Buffon, Antonino & Bliden, Kevin [Vis alle 13 forfattere av denne artikkelen] (2019). Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(1), s. 47–54. doi: 10.1093/ehjcvp/pvy038. Fulltekst i vitenarkiv
-
Fröhlich, Hanna; Rosenfeld, Nitzan; Täger, Tobias; Goode, Kevin; Kazmi, Syed & Hole, Torstein [Vis alle 13 forfattere av denne artikkelen] (2019). Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe. Heart. ISSN 1355-6037. 105(16), s. 1252–1259. doi: 10.1136/heartjnl-2018-314256.
-
Nero, Daniella; Agewall, Stefan; Daniel, Maria; Caidahl, Kenneth; Collste, Olov & Ekenbäck, Christina [Vis alle 17 forfattere av denne artikkelen] (2018). Personality traits in patients with myocardial infarction with nonobstructive coronary arteries. American Journal of Medicine. ISSN 0002-9343. 132(3), s. 374–381.e1. doi: 10.1016/j.amjmed.2018.11.010.
-
Vonbank, Alexander; Drexel, Heinz; Agewall, Stefan; Lewis, Basil S.; Dopheide, Jörn Fredrik & Kjeldsen, Keld [Vis alle 15 forfattere av denne artikkelen] (2018). Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 4(4), s. 230–236. doi: 10.1093/ehjcvp/pvy028.
-
Daniel, Maria; Agewall, Stefan; Berglund, Felix; Caidahl, Kenneth; Collste, Olov & Ekenbäck, Christina [Vis alle 17 forfattere av denne artikkelen] (2018). Prevalence of anxiety and depression symptoms in patients with myocardial infarction with non-obstructive coronary arteries. American Journal of Medicine. ISSN 0002-9343. 131(9), s. 1118–1124. doi: 10.1016/j.amjmed.2018.04.040.
-
Serebruany, Victor L.; Hall, Trygve Sørdahl; Atar, Dan; Agewall, Stefan; Kim, Moo Hyun & Geudelin, Bernhard [Vis alle 8 forfattere av denne artikkelen] (2018). Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System. Journal of Cardiovascular Pharmacology. ISSN 0160-2446. 5(4), s. 210–215. doi: 10.1093/ehjcvp/pvy035.
-
Hall, Trygve Sørdahl; von Lueder, Thomas Gero; Zannad, Faiez; Rossignol, Patrick; Duarte, Kevin & Chouihed, Tahar [Vis alle 10 forfattere av denne artikkelen] (2018). Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction. International Journal of Cardiology. ISSN 0167-5273. 272, s. 260–266. doi: 10.1016/j.ijcard.2018.07.137.
-
Rosano, Giuseppe M.C.; Tamargo, Juan; Kjeldsen, Keld P.; Lainscak, Mitja; Agewall, Stefan & Anker, Stefan D. [Vis alle 20 forfattere av denne artikkelen] (2018). Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: Coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 4(3), s. 180–188. doi: 10.1093/ehjcvp/pvy015.
-
Niessner, Alexander; Tamargo, Juan; Koller, Lorenz; Saely, Christoph H.; Schmidt, Thomas Andersen & Savarese, Gianluigi [Vis alle 16 forfattere av denne artikkelen] (2018). Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European Heart Journal. ISSN 0195-668X. 39(24), s. 2274–2281. doi: 10.1093/eurheartj/ehx625.
-
Agewall, Stefan (2023). Cardiovascular preventive actions. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(6), s. 497–498. doi: 10.1093/ehjcvp/pvad054.
-
Agewall, Stefan (2023). Atrial fibrillation has gone from a boring disease to a very hot condition. Why is that? European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(5), s. 401–402. doi: 10.1093/ehjcvp/pvad049.
-
Agewall, Stefan (2023). Focus on prevention in diabetes mellitus and lipid disorder. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(4), s. 295–296. doi: 10.1093/ehjcvp/pvad037.
-
Agewall, Stefan (2023). A tailor-made suit always fits best. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(3), s. 199–200. doi: 10.1093/ehjcvp/pvad024.
-
Agewall, Stefan (2023). Focus on lipid treatment. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(2), s. 119–120. doi: 10.1093/ehjcvp/pvad007.
-
Aunan, Kristin; Atar, Dan & Agewall, Stefan (2023). Klima - en hjertesak. Hjerteforum. ISSN 0802-1465. 1, s. 54–61.
-
Agewall, Stefan (2022). Pharmacological treatment of CVD. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(1), s. 1–3. doi: 10.1093/ehjcvp/pvac068.
-
Tamargo, Juan; Hasegawa, Koji & Agewall, Stefan (2022). Toward personalized medicine for cardiovascular pharmacotherapy. European Heart Journal. ISSN 0195-668X. 43(45), s. 4719–4721. doi: 10.1093/eurheartj/ehac413.
-
Agewall, Stefan (2022). Future of European Heart Journal Cardiovascular Pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(8). doi: 10.1093/ehjcvp/pvac061.
-
Agewall, Stefan (2022). To treat or not to treat. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(8), s. 754–755. doi: 10.1093/ehjcvp/pvac062.
-
Agewall, Stefan (2022). Treating patients with anticoagulants and antiplatelet drugs is always a balance between risk for thrombosis vs. risk for bleeding. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(7), s. 645–647. doi: 10.1093/ehjcvp/pvac048.
-
Agewall, Stefan (2022). Prevention is still the key to success. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(6), s. 537–538. doi: 10.1093/ehjcvp/pvac046.
-
Agewall, Stefan (2022). Focus on optimizing treatment of coronary heart disease. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(5), s. 431–433. doi: 10.1093/ehjcvp/pvac039.
-
Agewall, Stefan (2022). New cardiology aspects of triple antithrombotic therapy, diabetes without insulin therapy as a risk factor in atrial fibrillation, treatment of gout, cholesterol lowering treatment, prostate cancer treatment, out-of-hospital cardiac arrest, Fabry disease, beta-blocker use after myocardial infarction in patients with normal ejection fraction, cardio-renal benefits of SGLT2 Inhibitors and interpretation of clinical trials. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(3), s. 213–215. doi: 10.1093/ehjcvp/pvac019.
-
Agewall, Stefan (2022). Focus on different aspects of atrial fibrillation. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(4), s. 323–324. doi: 10.1093/ehjcvp/pvac035.
-
Agewall, Stefan (2022). Optimizing individual heart failure treatment. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(2), s. 105–107. doi: 10.1093/ehjcvp/pvab087.
-
Agewall, Stefan (2022). Treatment with dual antiplatelet therapy after an acute coronary event may often be tailor-made for the patient. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(1), s. 1–3. doi: 10.1093/ehjcvp/pvab078.
-
Agewall, Stefan (2021). Different aspects of giving the optimal antiplatelet treatment. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 7(3), s. 169–170. doi: 10.1093/ehjcvp/pvab037.
-
Agewall, Stefan (2021). Adherence to pharmacological treatment: How can we improve? European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 7(4), s. 261–262. doi: 10.1093/ehjcvp/pvab049.
-
Agewall, Stefan (2021). Antiplatelet treatment in coronary syndrome. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 7(2), s. 81–82. doi: 10.1093/ehjcvp/pvab015.
-
Agewall, Stefan (2021). Unsolved pharmacological issues with cardiology. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 7(6), s. 461–462. doi: 10.1093/ehjcvp/pvab077.
-
Agewall, Stefan (2021). More knowledge about atrial fibrillation, still we need to learn. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 7(5), s. 361–362. doi: 10.1093/ehjcvp/pvab067.
-
Agewall, Stefan (2021). Atrial fibrillation in registries. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 7(1), s. 1–2. doi: 10.1093/ehjcvp/pvaa142.
-
Agewall, Stefan (2020). Focus on blood pressure and risk factor intervention. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(6), s. 339–340. doi: 10.1093/ehjcvp/pvaa130.
-
Agewall, Stefan (2020). Focus on subpopulations of atrial fibrillation patients. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(3), s. 131–132. doi: 10.1093/ehjcvp/pvaa034.
-
Agewall, Stefan (2020). Lipids and antithrombotic treatment. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(2). doi: 10.1093/ehjcvp/pvaa014.
-
Agewall, Stefan (2020). Focus on pharma in acute coronary syndrome. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(1), s. 1–2. doi: 10.1093/ehjcvp/pvz074.
-
Agewall, Stefan (2020). Minimizing bleeding events. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(5), s. 271–272. doi: 10.1093/ehjcvp/pvaa100.
-
Hall, Trygve Sørdahl; Orn, S; Zanned, F.; Rossignol, Patrick; Duarte, K. & Solomon, S. [Vis alle 10 forfattere av denne artikkelen] (2020). The association of smoking to cardiovascular death differs according to age and sex following myocardial infarction complicated by heart failure or left ventricular dysfunction .
-
Agewall, Stefan (2020). Can we offer tailor-made pharmacological treatment of patients with acute coronary syndrome? European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(4), s. 201–202. doi: 10.1093/ehjcvp/pvaa075.
-
Agewall, Stefan (2019). European Heart Journal - Cardiovascular Pharmacotherapy: Now accepted for an official Impact Factor. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(2). doi: 10.1093/ehjcvp/pvz009.
-
Agewall, Stefan (2019). Antiplatelet treatment in acute coronary syndrome. Still an issue. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(3), s. 125–126. doi: 10.1093/ehjcvp/pvz018.
-
Agewall, Stefan (2019). European Heart Journal - Cardiovascular Pharmacotherapy has received its first Impact Factor of 6.723. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(4), s. 183–184. doi: 10.1093/ehjcvp/pvz041.
-
Agewall, Stefan (2019). Unsolved issues in oral anticoagulation treatment in atrial fibrillation. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(2), s. 60–61. doi: 10.1093/ehjcvp/pvz008.
-
Marciniak, Thomas A.; Hall, Trygve Sørdahl; Atar, Dan; Agewall, Stefan & Serebruany, Victor L. (2019). Ivabradine for heart failure: Regulatory differences in Europe and United States. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(2), s. 119–121. doi: 10.1093/ehjcvp/pvz006.
-
Agewall, Stefan (2019). Old and new drugs in cardiovascular pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(1), s. 1–2. doi: 10.1093/ehjcvp/pvy046.
-
Agewall, Stefan (2018). New input on antiplatelet treatment and registry studies. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 4(3), s. 129–130. doi: 10.1093/ehjcvp/pvy016.
-
Agewall, Stefan (2018). Cardiovascular pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 4(1). doi: 10.1093/ehjcvp/pvx036.
-
Niessner, Alexander & Agewall, Stefan (2018). Critical appraisal of the COMPASS trial. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 4(4), s. 191–192. doi: 10.1093/ehjcvp/pvy027.
-
von Lueder, Thomas Gero & Agewall, Stefan (2018). The burden of heart failure in the general population: A clearer and more concerning picture. Journal of Thoracic Disease (JTD). ISSN 2072-1439. 10, s. S1934–S1937. doi: 10.21037/jtd.2018.04.153.
-
Agewall, Stefan (2018). Adherence to guidelines, compliance to treatment, and treatment quality. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 4(4), s. 189–190. doi: 10.1093/ehjcvp/pvy033.
-
Agewall, Stefan (2018). Cardiovascular pharmacotherapy and real-world data. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 4(2), s. 65–66. doi: 10.1093/ehjcvp/pvy008.
Publisert
12. des. 2011 11:24
- Sist endret
8. mars 2017 20:03